Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)

Market Cap	1.48B
Revenue (ttm)	495.63M
Net Income (ttm)	7.39M
Shares Out	20.80M
EPS (ttm)	0.36
PE Ratio	197.11
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	72,759
Average Volume	28,163
Open	73.99
Previous Close	70.96
Day's Range	71.50 - 77.70
52-Week Range	54.00 - 90.98
Beta	0.31
RSI	45.14
Earnings Date	May 23, 2025

About NSE:LOTUSEYE

Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE lasik, touch free laser, lasik eye surgery, epilasik, intralase, supracor, robotic femto laser cataract surgery, phacoemulsification, paediatric eye care and squint surgery, and micro incision cataract surgery treatments. It also provides epizyoptix, special kertometer, and synaptophore; SICS, Phaco, MICS, LRCS, SFLOL, and SF IOL cataract surgery; corneal patchgraft, scleral repair, scrapping +...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1989
• Employees: 336
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: LOTUSEYE

Financial Performance

In 2024, NSE:LOTUSEYE's revenue was 495.63 million, an increase of 2.81% compared to the previous year's 482.10 million. Earnings were 7.39 million, a decrease of -74.63%.